Your browser doesn't support javascript.
loading
Phase III randomized, double-blind study of paclitaxel with and without everolimus in patients with advanced gastric or esophagogastric junction carcinoma who have progressed after therapy with a fluoropyrimidine/platinum-containing regimen (RADPAC).
Lorenzen, Sylvie; Knorrenschild, Jorge Riera; Pauligk, Claudia; Hegewisch-Becker, Susanna; Seraphin, Jörg; Thuss-Patience, Peter; Kopp, Hans-Georg; Dechow, Tobias; Vogel, Arndt; Luley, Kim Barbara; Pink, Daniel; Stahl, Michael; Kullmann, Frank; Hebart, Holger; Siveke, Jens; Egger, Matthias; Homann, Nils; Probst, Stephan; Goetze, Thorsten Oliver; Al-Batran, Salah-Eddin.
Afiliação
  • Lorenzen S; Third Department of Internal Medicine (Hematology/Medical Oncology), Klinikum Rechts der Isar, Technische Universität München, Munich, Germany.
  • Knorrenschild JR; Department of Hematology and Oncology, Universitätsklinikum Giessen und Marburg, Marburg, Germany.
  • Pauligk C; Krankenhaus Nordwest, University Cancer Center, Frankfurt, Germany.
  • Hegewisch-Becker S; Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest, Frankfurt, Germany.
  • Seraphin J; HOPE-Hämatologisch-Onkologische Praxis Eppendorf, Hamburg, Germany.
  • Thuss-Patience P; Helios MVZ Südniedersachsen GmbH, Northeim, Germany.
  • Kopp HG; Department of Hematology, Oncology and Tumor Immunology, Charite-University Medicine Berlin, Berlin, Germany.
  • Dechow T; University Hospital, Medical Center II, Tuebingen, Germany.
  • Vogel A; Onkologie Ravensburg, Ravensburg, Germany.
  • Luley KB; Hannover Medical School, Hannover, Germany.
  • Pink D; UKSH Campus Luebeck, Lübeck, Germany.
  • Stahl M; Helios Klinikum Bad Saarow, Department of Internal Medicine- Hematology, Oncology and Stem Cell Transplantation, Greifswald University Hospital, Greifswald, Germany.
  • Kullmann F; Department of Medical Oncology, Evang. Kliniken Essen-Mitte gGmbH, Essen, Germany.
  • Hebart H; First Department of Medicine, Nordoberpfalz Hospital, Weiden, Germany.
  • Siveke J; Stauferklinikum, Mutlangen, Germany.
  • Egger M; Second Department of Internal Medicine, Technical University, Munich, Germany.
  • Homann N; Institute for Developmental Cancer Therapeutics, West German Cancer Center, University Hospital Essen, Essen, Germany.
  • Probst S; Ortenau - Clinic Lahr Medical Clinic, Lahr, Germany.
  • Goetze TO; Department of Internal Medicine II, Academic Teaching Hospital Wolfsburg, Wolfsburg, Germany.
  • Al-Batran SE; Klinikum Bielefeld, Bielefeld, Germany.
Int J Cancer ; 147(9): 2493-2502, 2020 11 01.
Article em En | MEDLINE | ID: mdl-32339253
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Gástricas / Adenocarcinoma / Protocolos de Quimioterapia Combinada Antineoplásica / Junção Esofagogástrica / Mucosite Tipo de estudo: Clinical_trials Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Gástricas / Adenocarcinoma / Protocolos de Quimioterapia Combinada Antineoplásica / Junção Esofagogástrica / Mucosite Tipo de estudo: Clinical_trials Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article